en · de · es · fr · pt
cjc-1295-notes.peptides6908.com › Wiki › Background And Naming Conventions — Hands-On Walkthrough

Background And Naming Conventions — Hands-On Walkthrough

By Editorial Desk · published 2025-10-19 · last reviewed 2025-12-08 · Wiki

CJC-1295 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2025-12-08. Anything still debated is marked as such rather than presented as settled.

Background and Naming Conventions

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

CJC-1295 Structure And Mechanism

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

Cjc-1295 at a glance

PropertyValueNotes
Molecular classSynthetic peptideAnalog of growth hormone-releasing hormone
Chain length29 amino acidsBased on the GRF(1-29) fragment
AppearanceWhite to off-white lyophilized powderCommon research supply form
SolubilitySoluble in water and aqueous buffersPowder requires reconstitution before use
Typical storage−20 °C or belowKept away from light and moisture

Compound Identity and Development History

CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

Related pages on this site

Background and Molecular Design

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

Reference notes

== Causes == The NIH states: "The causes of most cases of reactive hypoglycemia are still open to debate. Some researchers suggest that certain people may be more sensitive to the body's normal release of the hormone epinephrine, which causes many of the symptoms of hypoglycemia. Others believe deficiencies in glucagon secretion might lead to reactive hypoglycemia. Several other hormones are responsible for modulating the body's response to insulin, including cortisol, growth hormone and sex hormones. Untreated or under-treated hormonal disorders such as adrenal insufficiency (see also Addison's disease) or growth hormone deficiency can therefore sometimes cause insulin hypersensitivity, and reactive hypoglycemia. Stomach bypass surgery or hereditary fructose intolerance are believed to be causes, albeit uncommon, of reactive hypoglycemia. Myo-inositol or 1D-chiro-inositol withdrawal can cause temporary reactive hypoglycemia. There are several kinds of reactive hypoglycemia:

=== Homeostasis === Copper is absorbed, transported, distributed, stored, and excreted in the body according to complex homeostatic processes which ensure a constant and sufficient supply of the micronutrient while simultaneously avoiding excess levels. If an insufficient amount of copper is ingested for a short period of time, copper stores in the liver will be depleted. Should this depletion continue, a copper health deficiency condition may develop. If too much copper is ingested, an excess condition can result. Both of these conditions, deficiency and excess, can lead to tissue injury and disease. However, due to homeostatic regulation, the human body is capable of balancing a wide range of copper intakes for the needs of healthy individuals. Many aspects of copper homeostasis are known at the molecular level. Copper's essentiality is due to its ability to act as an electron donor or acceptor as its oxidation state fluxes between Cu1+(cuprous) and Cu2+ (cupric). As a component of about a dozen cuproenzymes, copper is involved in key redox (i.e., oxidation-reduction) reactions in essential metabolic processes such as mitochondrial respiration, synthesis of melanin, and cross-linking of collagen. Copper is an integral part of the antioxidant enzyme copper-zinc superoxide dismutase, and has a role in iron homeostasis as a cofactor in ceruloplasmin. A list of some key copper-containing enzymes and their functions is summarized below:

== Applications == Advanced Metering Infrastructure (AMI)/Advanced Meter Reading (AMR): provides two way meter communications, allowing commands to be sent toward the home for multiple purposes, including “time-of-use” pricing information, demand-response actions, or remote service disconnects. During periods of peak demand, utilities use these networks to throttle high-load devices in participating homes. Utilities may also institute time-of-use pricing schemes, where the home area network (HAN) is used to communicate the current price of energy to the consumer. Home Automation: allows household devices such as light switches and fixtures; thermostats and sensors; music, video and speaker systems; security controllers and appliances to network with one another to wirelessly automate the home. Hospitality: allows for wireless networking of the devices in the room without the need for a retrofit. The doors and the devices in the rooms can also be remotely monitored from a central location. Building Automation: provides building owners and property managers with HVAC, lighting, access and refrigeration control to monitor energy usage in real time to create more energy efficient environments. Asset Management: allows for remote monitoring and tracking of assets and cold chain. It also provides container security in shipping. Industrial Automation: wirelessly networks and automates industrial processes and allows for temperature, pressure and level sensing as well as providing temperature and flow control. Defense: provides both battlefield and shipboard monitoring.

=== Immune system === Ghrelin has a diverse immunoregulatory role mediating the release of anti-inflammatory cytokines such as IL-4 and 10 along with TGF-β while reducing pro-inflammatory cytokines such as TNF-α, INF-γ, and IL-1β from various immunologically competent cells in vitro and in vivo. Additionally, Ghrelin and its endogenous receptor, GHSR1a, along with GOAT are expressed in primary immune tissues such as the spleen and thymus where it has a role in modulating interactions between metabolic state and inflammation, mediating energy balance homeostasis.

Sources: en.wikipedia.org

Reference notes

September 21: Malta becomes independent from the UK. September 24: The Mozambican War of Independence begins in Portuguese Mozambique. October 12: The first spaceflight to carry multiple crewman into orbit was conducted by Voskhod 1. October 14: Leonid Brezhnev succeeds Khrushchev to become General Secretary of the Communist Party of the Soviet Union, with Alexei Kosygin as his Premier. October 16: China tests its first atomic bomb. The test makes China the world's fifth nuclear power. October 24: Northern Rhodesia renamed Zambia becomes independent from the UK. November 28: Mariner 4 was launched.

=== Early life === Dyson was born on 15 December 1923, in Crowthorne in Berkshire, England. He was the son of Mildred (née Atkey) and the composer George Dyson, who was later knighted. His mother had a law degree, and after Dyson was born she worked as a social worker. Dyson had one sibling, his older sister, Alice, who remembered him as a boy surrounded by encyclopaedias and always calculating on sheets of paper. At the age of four he tried to calculate the number of atoms in the Sun. As a child, he showed an interest in large numbers and in the Solar System, and was deeply influenced by Eric Temple Bell's Men of Mathematics (1937). Politically, Dyson said he was "brought up as a socialist". He wrote that "One of my grandmothers was a notorious and successful faith healer. One of my cousins was for many years the editor of the Journal of the Society for Psychical Research. Both of these ladies were well educated, highly intelligent, and fervent universelle in paranormal phenomenon. They may have been deluded, but neither of them was a fool." From 1936 to 1941 Dyson was a scholar at Winchester College, where his father was Director of Music. At the age of 17 he studied pure mathematics with Abram Besicovitch as his tutor at Trinity College, Cambridge, where he won a scholarship at age 15. During this stay, Dyson also practised night climbing on the university buildings, and once walked from Cambridge to London in a day with his friend Oscar Hahn, nephew of Kurt Hahn, who was a wheelchair user due to polio.

== Flow control == There are various ways to control the fluid flow in the channels. They include changing the channel width and length, altering the wettability of the paper, diverting some fluid through a parallel channel, or changing the viscosity of the fluid. The flow in PADs can be turned off with dissolvable sugar bridges, Corona discharge treatment to alter a coating on the paper from a hydrophobic to hydrophilic state, or the use of an expandable polymer triggered by the flow to close the flow path.

Sources: en.wikipedia.org

Frequently asked questions

Does this compound occur naturally in the body?

No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.

What does the abbreviation DAC refer to?

DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.

Why do different sources report different half-lives for the same name?

Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.

How does CJC-1295 differ from modified GRF(1-29)?

The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.

Network